BICNU

This brand name is authorized in Canada, Spain, France, Hong Kong, New Zealand, Singapore, Tunisia, Turkey

Active ingredients

The drug BICNU contains one active pharmaceutical ingredient (API):

1 Carmustine UNII U68WG3173Y - CARMUSTINE

Carmustine is a cell-cycle phase nonspecific antineoplastic agent of the nitrosourea type. As an alkylating agent, it can alkylate reactive sites on nucleoproteins, thus interfering with DNA and RNA synthesis and DNA repair. In addition, carmustine is known to carbamoylate lysine residues on proteins causing irreversible inactivation of enzymes including glutathione reductase. Read about Carmustine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AD01	Carmustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AD Nitrosoureas
Discover more medicines within L01AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00297763
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 80523
Country: FR	Base de données publique des médicaments	Identifier(s): 61918795
Country: HK	Department of Health Drug Office	Identifier(s): 05144
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2116
Country: SG	Health Sciences Authority	Identifier(s): 15502P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5253011H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680952000260